Cytokinetics
CYTK
#2440
Rank
ยฃ5.40 B
Marketcap
ยฃ38.80
Share price
-1.32%
Change (1 day)
-21.63%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): -ยฃ4.54

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -ยฃ4.62. In 2025 the company made an earnings per share (EPS) of -ยฃ4.99 a decrease over its 2024 EPS that were of -ยฃ4.02.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ4.54-9.02%
2025-ยฃ4.9924.14%
2024-ยฃ4.02-3.49%
2023-ยฃ4.1628.24%
2022-ยฃ3.2550.18%
2021-ยฃ2.1640.8%
2020-ยฃ1.54
2018-ยฃ1.49-24.12%
2017-ยฃ1.96-776.32%
2016ยฃ0.29-139.18%
2015-ยฃ0.74125.58%
2014-ยฃ0.33-67.67%
2013-ยฃ1.02-44.58%
2012-ยฃ1.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
ยฃ13.28-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-ยฃ26.55 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.98-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ38.44 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-ยฃ0.88-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA